Kither Biotech
PrivateLast Round
Series B
Mar 16, 2022
Total Funding Raised
$26.58M
Company Overview
Kither Biotech operates in Healthcare & Life Sciences and is based in Turin. Its latest recorded funding round was a Series B round in March 2022.
Kither Biotech is a biotechnology company developing signal transduction modulators for the treatment of rare respiratory diseases such as cystic fibrosis and idiopathic pulmonary fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kither Biotech Comparables
Compare Kither Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enterprise Therapeutics | 86% | |
| ReCode Therapeutics | 79% | |
| Aer Therapeutics | 77% |
For institutional investors. Book with your work email.
Kither Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 16, 2022 | ||||
| Series A | Jul 5, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kither Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elysia Capital | Series A |
| 3B FUTURE Health Fund | Series B |
| Moschini Spa | Series A |
| Club degli Investitori | Series A, Series B |
| Claris Ventures | Series B |
| 2invest AG | Series B |
| CDP Venture Capital SGR | Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 35% MoM, reaching 1K.
- Mar 16, 2022
$20.26M raised in Series B funding.
For institutional investors. Book with your work email.
Kither Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kither Biotech's valuation, stock price, and market status.
Is Kither Biotech a public or private company?
Kither Biotech is a private company.
What is the current stock price of Kither Biotech?
Kither Biotech is a private company, so its shares have no public market price. Caplight tracks Kither Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kither Biotech worth (valuation)?
Valuation information for Kither Biotech is not publicly available.
Can I buy Kither Biotech stock?
Kither Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kither Biotech's last funding round?
Kither Biotech's most recent funding round was Series B on March 16, 2022.
Who are the main investors in Kither Biotech?
Key investors in Kither Biotech include Claris Ventures, 2invest AG.
Will Kither Biotech IPO soon?
No public IPO plans have been announced for Kither Biotech.
How can I track Kither Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Kither Biotech's shares on secondary markets.